Cutix Plc (NGX:CUTIX)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions NGN. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Capitalization	27,477	17,120	10,920	7,926	8,595	3,893
Market Cap Growth	56.77%	56.77%	37.78%	-7.79%	120.81%	82.64%
Enterprise Value	29,505	18,994	12,759	8,687	9,811	4,964
Last Close Price	3.90	2.43	1.50	1.04	1.07	0.47
PE Ratio	26.63	16.59	10.25	10.03	10.93	6.55
PS Ratio	1.74	1.09	0.90	0.86	1.09	0.58
PB Ratio	6.46	4.03	2.87	2.50	3.18	1.81
P/TBV Ratio	6.46	4.03	2.87	2.50	3.18	1.81
P/FCF Ratio	92.70	57.76	18.36	31.92	9.24	83.30
P/OCF Ratio	16.51	10.29	11.01	15.24	7.28	13.02
EV/Sales Ratio	1.87	1.20	1.05	0.94	1.25	0.74
EV/EBITDA Ratio	16.88	10.87	6.42	5.68	6.62	4.10
EV/EBIT Ratio	18.94	12.19	6.94	6.71	7.62	4.85
EV/FCF Ratio	99.54	64.08	21.45	34.98	10.55	106.21
Debt / Equity Ratio	0.51	0.51	0.42	0.41	0.40	0.72
Debt / EBITDA Ratio	1.24	1.24	0.81	0.85	0.73	1.28
Debt / FCF Ratio	7.32	7.32	2.70	5.25	1.16	33.06
Asset Turnover	1.97	1.97	1.86	1.69	1.59	1.60
Inventory Turnover	3.03	3.03	2.79	2.43	2.22	2.38
Quick Ratio	0.13	0.13	0.13	0.15	0.19	0.10
Current Ratio	1.52	1.52	2.11	1.93	1.85	1.61
Return on Equity (ROE)	25.61%	25.61%	30.55%	26.91%	32.36%	29.99%
Return on Assets (ROA)	12.19%	12.19%	17.50%	14.76%	16.25%	15.20%
Return on Capital (ROIC)	16.46%	16.46%	23.25%	19.60%	21.52%	19.36%
Return on Capital Employed (ROCE)	33.70%	33.70%	41.10%	38.00%	44.10%	42.00%
Earnings Yield	3.76%	6.03%	9.75%	9.97%	9.15%	15.26%
FCF Yield	1.08%	1.73%	5.45%	3.13%	10.82%	1.20%
Dividend Yield	2.56%	4.12%	4.99%	5.76%	4.66%	7.92%
Payout Ratio	51.21%	51.21%	39.68%	44.59%	33.60%	37.06%
Total Shareholder Return	2.56%	4.12%	4.99%	5.76%	4.66%	7.92%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.